BSPM [Biostar Pharmaceuticals] 8-K: Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination
[Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq XIANYANG, China, August 23, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announc]